Alzheimer’s disease (AD) is a chronic progressive neurodegenerative disease classically characterized by memory loss, cognition impairment, and progressive β-amyloid (Aβ) and phosphorylated tau accumulation, ultimately causing loss of neurons and synapses, brain atrophy, and even death [1]. Here, MAPT is linked to Alzheimer disease.